Skip to main content

Table 2 24 hours glucose levels measured by CGM and 1,5-AG levels

From: A pilot study of the efficacy of miglitol and sitagliptin for type 2diabetes with a continuous glucose monitoring system and incretin-related markers

  Case 1 Case 2 Case 3
Glucose (mg/dl) (Average ± SD)    
   no medication 120 ± 34 193 ± 44 161 ± 55
   miglitol 131 ± 19 164 ± 24 131 ± 43
   miglitol + sitagliptin 120 ± 14 156 ± 20 151 ± 21
1,5-AG (μg/ml)    
   no medication 8.5 5.9 17.6
   miglitol 8.2 6.8 17.7
   miglitol + sitagliptin 8.8 7.9 17.9
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840